Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2009
05/28/2009US20090137394 Zea mays nfb2 promoter
05/28/2009US20090137051 Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau
05/28/2009US20090137050 Artificial protein, method for absolute quantification of proteins and uses thereof
05/28/2009US20090137046 Splicing-Mediated Regulation Of Gene Expression
05/28/2009US20090137045 Pyridinium Cationic Lipids as Gene Transfer Agents
05/28/2009US20090137040 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
05/28/2009US20090137039 Targeting opposite strand replication intermediates of single-stranded viruses by rnai
05/28/2009US20090137037 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate
05/28/2009US20090137036 Tweak receptor
05/28/2009US20090137035 Tweak receptor
05/28/2009US20090137033 Novel fluorescent proteins from aequorea coerulscens and methods for using same
05/28/2009US20090137020 Method of reverse transcription
05/28/2009US20090137019 Thermostable luciferases and methods of production
05/28/2009US20090137012 Process for producing lactonase and utilitzation thereof
05/28/2009US20090137007 Method for sequencing nucleic acid molecules
05/28/2009US20090137006 Sugar Kinases with Expanded Substrate Specificity and Their Use
05/28/2009US20090137005 IL-12 for Expression in Mammalian Cell
05/28/2009US20090137004 Artificial entropic bristle domain sequences and their use in recombinant protein production
05/28/2009US20090137003 Methods for recombinant manufacturing of anti-RSV antibodies
05/28/2009US20090137002 Anti ephb4 antibodies and antibody fragments
05/28/2009US20090137000 Dna polymerases and related methods
05/28/2009US20090136998 Luciferases and methods for making and using the same
05/28/2009US20090136997 Pro1550 polypeptides and nucleic acids encoding the same
05/28/2009US20090136996 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof
05/28/2009US20090136995 Mutated Prokaryotic Cells with High Secretion-Levels
05/28/2009US20090136994 Polypeptide having amidase activity and gene thereof
05/28/2009US20090136986 Methods and cells for creating functional diversity and uses thereof
05/28/2009US20090136983 Target sequences for synthetic molecules
05/28/2009US20090136975 transient receptor potential (TRP) family of ion channels; recombinant vectors, host cells; high throughput screening, drug screening
05/28/2009US20090136970 Nogo receptor homologues and their use
05/28/2009US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
05/28/2009US20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses
05/28/2009US20090136957 Methods and compositions for regulating cell cycle progression via the miR-106B family
05/28/2009US20090136950 Immunoglobulin display vectors
05/28/2009US20090136939 Methods for diagnosis and therapy for pancreatic cancer and composition useful therein
05/28/2009US20090136934 Targeting and tracing of antigens in living cells
05/28/2009US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor
05/28/2009US20090136924 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation
05/28/2009US20090136914 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
05/28/2009US20090136624 Lactic acid bacteria producing nisin at high concentration and method for selecting the same
05/28/2009US20090136552 Growth factors nsg28, nsg30, and nsg32
05/28/2009US20090136544 Interfering RNAs Targeting the Morbillivirus Nucleoprotein Gene
05/28/2009US20090136536 Recombinant Subunit Vaccine
05/28/2009US20090136530 Influenza Hemagglutinin and Neuraminidase Variants
05/28/2009US20090136528 Novel immunogenic epitope for immunotherapy
05/28/2009US20090136526 CD19 Binding Agents and Uses Thereof
05/28/2009US20090136524 Compositions and methods for diagnosis and treatment of tumors
05/28/2009US20090136523 Anti-cd26 antibodies and methods of use thereof
05/28/2009US20090136516 Cd-20 specific antibodies and methods of employing same
05/28/2009US20090136510 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
05/28/2009US20090136508 Method of diagnosing colon and gastric cancers
05/28/2009US20090136507 HBM variants that modulate bone mass and lipid levels
05/28/2009US20090136506 Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target
05/28/2009US20090136503 Trail receptor-binding agents and uses of the same
05/28/2009US20090136495 useful therapeutically for increasing serum iron levels, reticulocyte count, red blood cell count, hemoglobin, and/or hematocrit in a human; anemia
05/28/2009US20090136484 Novel antibody molecules and nucleic acids
05/28/2009US20090136483 Compositions and Methods for Binding Lysophosphatidic Acid
05/28/2009US20090136479 Ubiquitin-like protein isg15 for hiv inhibition
05/28/2009US20090136476 Arabinofuranosidases
05/28/2009US20090136475 Immunokinases
05/28/2009US20090136467 Apolipoprotein analogues
05/28/2009US20090136466 Methods for making skin cell derived stem cells
05/28/2009US20090136465 Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
05/28/2009US20090136464 Methods and compositions for cell therapy
05/28/2009US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents
05/28/2009US20090136453 Methods for treating pain
05/28/2009US20090136452 Contacting the target cell with a recombinant HSV particle comprising an altered gD forming a fusion with a peptide ligand to a receptor specific to the cell wherein the altered gD exhibits reduced binding to at least one of the cellular receptors of wild type gD; cell imaging; gene therapy; kits
05/28/2009US20090136451 Humanised Baculovirus
05/28/2009US20090136428 High Throughput Genetic Screening Of Lipid And Cholesterol Processing Using Fluorescent Compounds
05/28/2009US20090136420 Neoplasm-specific polypeptides and their uses
05/28/2009US20090136418 Peptides specific for hepatocellular carcinoma cells and applications thereof
05/28/2009US20090133633 In ovo activation of an egg in the shell
05/28/2009DE102007056836A1 Peptid-Antibiotikum aus Hydra sowie hierfür codierendes Gen Peptide antibiotic from Hydra and this encoding gene
05/28/2009DE102007056398A1 Flexibles Extraktionsverfahren für die Herstellung sequenzspezifischer Molekülbibliotheken Flexible extraction process for the production of sequence-specific molecule libraries
05/28/2009DE102005031910B4 Verfahren zum Stabilisieren von Nukleinsäuren A method for stabilizing nucleic acids
05/28/2009CA2709720A1 Maize with increased tolerance to fungal diseases
05/28/2009CA2706882A1 Bone morphogenic protein binding peptide
05/28/2009CA2706506A1 Plants having increased yield-related traits and a method for making the same
05/28/2009CA2706439A1 Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants
05/28/2009CA2706324A1 Transformation of crambe abyssinica
05/28/2009CA2706204A1 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-gmp synthesis obtained by said method
05/28/2009CA2706201A1 Peptides with capacity to bind to scurfin and applications
05/28/2009CA2705941A1 Glucoamylase variants with altered properties
05/28/2009CA2704654A1 Succinic acid production in a eukaryotic cell
05/28/2009CA2703903A1 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof
05/27/2009EP2062980A2 Methods and sequences to preferentially suppress expression of mutated huntingtin gene.
05/27/2009EP2062977A1 Fucosyltransferase-gen
05/27/2009EP2062976A2 Site specific incorporation of keto amino acids into proteins
05/27/2009EP2062975A1 Method for production of l-glutamic acid
05/27/2009EP2062974A1 Method of producing fused protein
05/27/2009EP2062973A1 TRACE mRNA AMPLIFICATION METHOD AND USE THEREOF
05/27/2009EP2062972A1 Novel vaccine for dog
05/27/2009EP2062971A1 Chimeric adenovirus, method for producing the same and pharmaceutical using the same
05/27/2009EP2062966A1 Material for control of soil-borne disease in plant utilizing novel filamentous fungi
05/27/2009EP2062919A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
05/27/2009EP2062918A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
05/27/2009EP2062917A2 Antibodies to erythropoietin receptor and uses thereof
05/27/2009EP2062913A1 Toxoplasma GONDII antigens, P35, and uses thereof
05/27/2009EP2062590A1 Peptide derived from Hepatitis C virus
05/27/2009EP2062589A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation
1 ... 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 ... 4023